Prevalence and clinical outcomes of incidentally diagnosed hypertrophic cardiomyopathy
- PMID: 20451692
- DOI: 10.1016/j.amjcard.2009.12.066
Prevalence and clinical outcomes of incidentally diagnosed hypertrophic cardiomyopathy
Abstract
The purpose of the present study was to evaluate the prevalence and prognosis of patients incidentally diagnosed with hypertrophic cardiomyopathy (HC). We studied 380 consecutive patients with HC (49.3 +/- 17.2 years; 65% men) for a median of 58 months (range 6 to 454). The patients were divided into 2 groups: those incidentally diagnosed from routine examination findings (precordial murmur and/or abnormal electrocardiographic findings) and those diagnosed either because of symptomatic status or by screening because of a family history of HC. Those patients who had been incidentally diagnosed constituted 29.2% of our study cohort. Although overall mortality did not differ between the 2 groups (p = 0.12), the patients diagnosed either because of symptoms or a family history tended to have at least a 4.5-fold greater risk of cardiovascular death (relative risk 4.5, 95% confidence interval 1.04 to 19.6, p = 0.04) and a 4.22 greater risk of sudden death (relative risk 4.22, 95% confidence interval 1.0 to 18.22, p = 0.04). Despite the greater sudden death mortality among the nonincidentally diagnosed patients, no statistically significant difference was found concerning the sudden death risk factor frequency (p = 0.96) between the 2 groups. In conclusion, the discrepancy between the low numbers of patients reported by published registries and the relatively high prevalence of the disease in the general population can be attributed to the large number of patients who remain asymptomatic, even throughout their life, awaiting an accidental diagnosis. Those patients with an incidental diagnosis have a more benign course, as shown by the total cardiovascular and composite sudden death mortality. A high level of awareness and suspicion for HC among physicians is essential for clinical recognition of such patients.
Copyright 2010 Elsevier Inc. All rights reserved.
Similar articles
-
Syncope and risk of sudden death in hypertrophic cardiomyopathy.Circulation. 2009 Apr 7;119(13):1703-10. doi: 10.1161/CIRCULATIONAHA.108.798314. Epub 2009 Mar 23. Circulation. 2009. PMID: 19307481
-
Determinants for clinical diagnosis of hypertrophic cardiomyopathy.Am J Cardiol. 2006 Dec 1;98(11):1507-11. doi: 10.1016/j.amjcard.2006.07.029. Epub 2006 Oct 12. Am J Cardiol. 2006. PMID: 17126660
-
The prevalence and clinical course of patients with 'incidental' acoustic neuromas.Acta Otolaryngol. 2007 Oct;127(10):1051-7. doi: 10.1080/00016480701200210. Acta Otolaryngol. 2007. PMID: 17851885
-
Hypertrophic cardiomyopathy: risk factors for life and living benefits insurance.J Insur Med. 2002;34(1):43-60. J Insur Med. 2002. PMID: 15303593 Review.
-
[Evaluation of the risk of sudden death in hypertrophic cardiomyopathy].Arch Mal Coeur Vaiss. 1999 Apr;92 Spec No 1:65-73. Arch Mal Coeur Vaiss. 1999. PMID: 10326160 Review. French.
Cited by
-
Patterns of Cardiomyopathy in Patients Presenting to a Tertiary Care Hospital.Cureus. 2025 Mar 18;17(3):e80794. doi: 10.7759/cureus.80794. eCollection 2025 Mar. Cureus. 2025. PMID: 40255771 Free PMC article.
-
Significance and Frequency of Incidental Fortuitous Clinical Identifications of Hypertrophic Cardiomyopathy.JACC Adv. 2024 Apr 25;3(6):100948. doi: 10.1016/j.jacadv.2024.100948. eCollection 2024 Jun. JACC Adv. 2024. PMID: 38938870 Free PMC article. No abstract available.
-
Hypertrophic cardiomyopathy in 2013: Current speculations and future perspectives.World J Cardiol. 2014 Feb 26;6(2):26-37. doi: 10.4330/wjc.v6.i2.26. World J Cardiol. 2014. PMID: 24575171 Free PMC article. Review.
-
Temporal Trend of Age at Diagnosis in Hypertrophic Cardiomyopathy: An Analysis of the International Sarcomeric Human Cardiomyopathy Registry.Circ Heart Fail. 2020 Sep;13(9):e007230. doi: 10.1161/CIRCHEARTFAILURE.120.007230. Epub 2020 Sep 8. Circ Heart Fail. 2020. PMID: 32894986 Free PMC article.
-
Clinical Characteristics and Healthcare Resource Utilization among Patients with Obstructive Hypertrophic Cardiomyopathy Treated in a Range of Settings in the United States.J Clin Med. 2022 Jul 4;11(13):3898. doi: 10.3390/jcm11133898. J Clin Med. 2022. PMID: 35807183 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources